Mollenhour Gross
Knoxville, United StatesInvestor highlights
- Industry generalist
- Yes
- Industry focus
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Analytics
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| CymaBay Therapeutics | Mar 25, 2024 | Biopharmaceutical, Clinical-stage, Investigational treatment, Liver Disease Therapies | - | 4300000000 USD | Newark, California |
| Oxos Medical | May 4, 2023 | Cloud Platform, Medical Imaging, MedTech, Teleradiology | Early stage | 23000000 USD | Atlanta, Georgia |
| PushPress | Aug 18, 2022 | Artificial Intelligence, Fitness, Management Platform, Software | Early stage | 11000000 USD | Claymont, Delaware |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.